Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Rittenmeyer Ronald A	2. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [ THC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive Chairman and CEO
(Last) (First) (Middle) 1445 ROSS AVENUE, SUITE 1400	3. Date of Earliest Transaction (MM/DD/YYYY) 11/29/2019
(Street) DALLAS, TX 75202 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ⁽¹⁾	11/29/2019		M		36083	A	⁽²⁾	315876	D
Common Stock	11/29/2019		F		14199 ⁽³⁾	D	$32.20	301677	D
Common Stock ⁽⁴⁾	11/29/2019		M		7307	A	⁽²⁾	308984	D
Common Stock	11/29/2019		F		2876 ⁽³⁾	D	$32.20	306108	D
Common Stock								15000	I	By spouse

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
2018 March Restricted Stock Units	⁽¹⁾	11/29/2019		M			36083	⁽¹⁾	⁽¹⁾	Common Stock ⁽⁵⁾	36083	$0.00	36083	D
2018 June Restricted Stock Units	⁽⁴⁾	11/29/2019		M			7307	⁽⁴⁾	⁽⁴⁾	Common Stock ⁽⁵⁾	7307	$0.00	7307	D

Explanation of Responses:
(1)	As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The seventh vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 36,083 restricted stock units are shown in Table II.
(2)	Restricted stock units convert into common stock on a one-for-one basis.
(3)	Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
(4)	As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The sixth vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 7,307 restricted stock units are shown in Table II.
(5)	Restricted stock units are settled in shares of the Company's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Rittenmeyer Ronald A 1445 ROSS AVENUE, SUITE 1400 DALLAS, TX 75202	X		Executive Chairman and CEO